|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of GT Biopharma (NASDAQ: GTBP) through any online brokerage.
The latest price target for GT Biopharma (NASDAQ: GTBP) was reported by HC Wainwright & Co. on May 24, 2021. The analyst firm set a price target for 25.00 expecting GTBP to rise to within 12 months (a possible 43.27% upside). 3 analyst firms have reported ratings in the last year.
The stock price for GT Biopharma (NASDAQ: GTBP) is $17.45 last updated Wed Jun 16 2021 20:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for GT Biopharma.
There is no upcoming split for GT Biopharma.
GT Biopharma is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.